Abstract Structure

The Team

At Datametrex, we believe that the right understanding and technological edge can lead companies towards a successful future. We always seek valuable feedback from our clients and investors in order to learn and evolve.

Contact us today to set up a meeting or request a demo.

Management

Chief Executive Officer
& Director
Marshall Gunter
Marshall Gunter

Chief Executive Officer
& Director

Mr. Gunter’s engineering background is rooted in big data analysis and machine learning at scale. Working with Sequoia Capital and Lightspeed Venture Partners, Marshall was responsible for bringing Varagesale to the mass market. Marshall took Varagesale from a one room shop to a powerhouse engineering department of 60 plus people and played a leading role in their $35-million-dollar raise. Marshall lead the team that built iSentium’s sentiment engine. iSentium uses patented Natural Language Processing (NLP) to extract sentiment from unstructured social content then instantly transforms it into highly actionable indicators in finance, brand management and politics, handling billions of data points to harness the power of the masses as they tweet and text.

CPA, CA
Chief Financial Officer
Don Shim
Don Shim
CPA, CA
Chief Financial Officer

Mr. Shim has led a successful accounting and finance career in both the US and Canada. He brings a wealth of knowledge to the team with his expertise in auditing publicly- traded junior mining companies and high-tech industries. Member of the Chartered Professional Accountants of British Columbia and a Certified Public Accountant registered in the State of Illinois, United States. Audit partner on numerous audit engagements for various publicly traded companies, primarily focusing on junior mining, oil and gas, pharmaceutical, and high-tech industries. Mr. Shim also assisted various start-up companies in achieving public listings on the TSX Venture Exchange, Canadian Securities Exchange and the OTC Market. In addition, Mr. Shim teaches accounting at a local college in Vancouver and acts as a facilitator at CPA Western School of Business, mentoring CPA candidates enrolled in the CPA Professional Education Program.

Chief Medical Officer
Dr. Omar Sharif
Dr. Omar Sharif

Chief Medical Officer

After receiving his training at University of Manitoba. Omar went on to take leading roles within his departments of hospital medicine and emergency medicine within BC and Alberta.  Working for over 10 years in these fields and gaining a status of clinical instructor at the University of British Columbia he has taught many students and interns.  He has now brought his skills and experience to help fill the ever growing void of top level community medicine and aid in it's implementation at Medi-call. A fierce believer in resilience, customers first, and team member engagement, Omar is driven by his passion to deliver innovative healthcare solutions and improve health outcomes for all Canadians

Chairman
Andrew Ryu
Andrew Ryu

Chairman

Andrew Ryu is a seasoned and experienced entrepreneur and operator in public and private companies with over 20 years of experience. Graduate of McMaster University and University of Toronto for Graduate Studies in Education. He is founder and former CEO of Loyalist Group Limited (TSXV: LOY), which was nominated as the top TSXV company in 2013, ranked fourth in 2014 and was the top pick of the street in 2014. He was nominated of EY Entrepreneur of the Year in 2014. He founder of Graph Blockchain Inc. (CSE: GBLC). As a founder of the Company. As founder of Datametrex AI Limited (TSXV: DM), he serves as Chairman from 2016.

Board of Directors

Paul Haber, 
C.P.A., C.A., C.Dir.
Board of Director
Paul Haber, 
C.P.A., C.A., C.Dir.

Board of Director

Mr. Haber has been involved in corporate finance and capital markets for over 20 years. He has served as the CFO and Audit Committee Chair of many public and private companies. Some of the Boards Mr. Haber has sat on includes, XTM Inc. (CSE:PAID), South American Silver Corp. (TSX:SAC), Migao Corporation (TSX:MGO), China Health and Diagnostics Inc. (TSXV:CHO), High Desert Gold Corp. (TSXV:HDG), and IND Dairytech Inc. (TSXV:IND). Mr. Haber has also served as the CFO of various public companies including, Oremex Gold (TSXV:OAG), SEL Exchange Inc. (TSXV:SEL). Leitch Technology Corp. (TSXV:LTV) and Migao Corporation (TSX:MGO). Mr. Haber started his career with Coopers & Lybrand (now PricewaterhouseCoppers LLP). He is both a Chartered Accountant and a Certified Public Accountant, with an Honours Bachelors of Arts Degree in Management from the University of Toronto. Mr. Haber was awarded his Chartered Director designation from the DeGroote School of Business in partnership with the Conference Board of Canada.

Benj Gallander
Board of Director
Benj Gallander

Board of Director

Mr. Gallander brings over 40 years of experience in the markets, with ample skills in integrating business and strategic investors and his know-how bringing innovation to companies. Over time, he has refined his approach to investing and has achieved one of the best track records in the investment industry. Mr. Gallander is a co-editor of Contra the Heard investment letter and over the past ten years the portfolio he manages achieved an annualized return of 18.4%. Benj co-writes "The Contra Guys" column for The Globe and Mail and is an author of three best-selling books, writes for several magazines, and has been a regular on BNN Bloomberg since virtually the beginning.

Hon. James S. Peterson, PC.
Board of Director
Hon. James S. Peterson, PC.

Board of Director

Mr. Peterson obtained his BA and LLB from Western University, his LLM from Columbia University, and his DCL from McGill University.  He is a member of the Ontario Bar Association and the Canadian Bar Association, and is a co-chair of the Canada-U.S. Law Institute. Mr. Peterson has also served for the government of Canada as minister of international trade, secretary of state (international financial institutions) and chair of the House of Commons standing committee on finance. While a cabinet minister, Mr. Peterson represented Canada at the World Trade Organization's Doha round of negotiations, which were focused on expanding trade and investment in leading emerging markets Brazil, Russia, India and China, and with complex issues related to trade with Canada's NAFTA partners, the European Union, the Middle East and the Americas.
Mr. Peterson served as chair of the House of Commons finance committee, where he began the practice of public prebudget hearings and completed several major studies, including a review of Canada's value-added tax (the GST). He retired from the House of Commons in 2007 after 23 years of public service as the member of Parliament for Willowdale (Toronto).​

Advisory Board

Advisor
Jeff Stevens
Jeff Stevens

Advisor

Jeff Stevens brings over 18 years of professional experience in the Canadian capital markets, largely focusing on raising capital for micro-cap and small-cap companies. He currently sits on the board of two public companies assisting with project selection and financing. He has worked on the retail, buy and sell sides of the industry, having held positions as Assistant Investment Advisor, Arbitrage Trader and was the head of two sales and trading desks for a US-based investment bank in Toronto. During his tenure, he was involved in raising over $500 million for public and private companies with a client base including institutional money managers, hedge funds, mutual funds and family offices in Canada, the US and Europe.

Advisor
Charles Schade
Charles Schade

Advisor

Charles Schade is a senior level marketing executive in the insights industry, with a proven track record for strategically identifying opportunities and launching new products successfully. He leads, motivates and attracts high-performance teams by inspiring staff and committing to ongoing coaching and mentoring. As a founder and former President of NPD Canada, and with over 25 years of sales and servicing experience, takes ownership of goals for companies and clients. He embraces industry leadership roles through speaking engagements at industry functions.

Medical Advisor
Dr. David Klein MD.
Dr. David Klein MD.

Medical Advisor

Dr. David Klein currently works in conjunction with Dr. Alexander Romaschin in the Department of Laboratory  Medicine at St. Michael’s Hospital on the development and clinical application of novel biomarkers to acute  care and critical care. He is also involved in the development of novel therapeutics targeting endotoxin in critical illness, as well as the linkage of diagnostics and therapeutics. Separately, he leads business strategy and  partnerships for the Applied Health Research Centre (AHRC) and holds advisory roles to government and other policy makers regarding the healthcare system and business strategy.